Core Laboratories Inc. $CLB Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC reduced its position in Core Laboratories Inc. (NYSE:CLB) by 6.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 774,979 shares of the oil and gas company’s stock after selling 49,600 shares during the quarter. Fisher Asset Management LLC’s holdings in Core Laboratories were worth $12,423,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. Hantz Financial Services Inc. boosted its holdings in shares of Core Laboratories by 124.7% in the fourth quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock valued at $51,000 after acquiring an additional 1,763 shares during the period. Abacus Wealth Partners LLC acquired a new stake in shares of Core Laboratories in the fourth quarter valued at approximately $233,000. Argos Wealth Advisors LLC acquired a new stake in shares of Core Laboratories in the fourth quarter valued at approximately $258,000. Pacific Ridge Capital Partners LLC boosted its holdings in shares of Core Laboratories by 4.7% in the fourth quarter. Pacific Ridge Capital Partners LLC now owns 44,423 shares of the oil and gas company’s stock valued at $712,000 after acquiring an additional 1,980 shares during the period. Finally, Swiss Life Asset Management Ltd acquired a new stake in shares of Core Laboratories in the fourth quarter valued at approximately $192,000. 97.81% of the stock is owned by institutional investors and hedge funds.

Core Laboratories Price Performance

Core Laboratories stock opened at $14.02 on Thursday. Core Laboratories Inc. has a 12 month low of $9.72 and a 12 month high of $20.36. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.05 and a quick ratio of 1.50. The business has a 50 day simple moving average of $15.60 and a 200-day simple moving average of $16.65. The stock has a market capitalization of $646.32 million, a PE ratio of 21.57, a price-to-earnings-growth ratio of 2.81 and a beta of 0.99.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The business had revenue of $121.80 million during the quarter, compared to analysts’ expectations of $122.99 million. During the same quarter in the prior year, the business earned $0.14 earnings per share. The company’s quarterly revenue was down 1.4% compared to the same quarter last year. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Equities analysts predict that Core Laboratories Inc. will post 0.56 earnings per share for the current year.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Monday, May 11th will be paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, May 11th. Core Laboratories’s dividend payout ratio is 6.15%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CLB. Weiss Ratings downgraded Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 4th. Wall Street Zen downgraded Core Laboratories from a “hold” rating to a “sell” rating in a report on Monday. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $12.00.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.